|By PR Newswire||
|September 5, 2014 06:00 AM EDT||
BEIJING, Sept. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis Healthcare & Technology Conference, to be held at the Wynn Las Vegas on September 12, 2014. Management will present at 8:00 am PT.
Please contact your Aegis representative to schedule a meeting with the Company.
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps and canine rabies. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, which it has supplied to the Chinese Government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government stockpiling program. Sinovac has filed a new drug application with the China Food & Drug Administration for its proprietary enterovirus 71 vaccine, having been proven effective in preventing hand, foot and mouth disease in infants and children during its Phase III trial. The company is currently developing a number of new products including a Sabin-strain inactivated polio vaccine, pneumococcal polysaccharides vaccine, pneumococcal conjugate vaccine and varicella vaccine. Sinovac primarily sells its vaccines in China, while also exploring growth opportunities in international markets. The Company has exported select vaccines to Mongolia, Nepal, the Philippines and Mexico, and was recently granted a license to commercialize its hepatitis A vaccine in Chile. For more information, please visit the Company's website at www.Sinovac.com .
Sinovac Biotech Ltd.
Helen Yang / Chris Lee
Tel: +86-10-8279-9659 / 9696
Email: [email protected]
Email: [email protected]
SOURCE Sinovac Biotech Ltd.
Dec. 11, 2016 08:45 AM EST Reads: 552
Dec. 11, 2016 08:00 AM EST Reads: 796
Dec. 11, 2016 07:30 AM EST Reads: 776
Dec. 11, 2016 07:00 AM EST Reads: 494
Dec. 11, 2016 06:45 AM EST Reads: 2,323
Dec. 11, 2016 05:45 AM EST Reads: 743
Dec. 11, 2016 05:30 AM EST Reads: 748
Dec. 11, 2016 05:00 AM EST Reads: 1,190
Dec. 11, 2016 04:45 AM EST Reads: 682
Dec. 11, 2016 04:30 AM EST Reads: 884
Dec. 11, 2016 03:30 AM EST Reads: 1,175
Dec. 11, 2016 03:00 AM EST Reads: 815
Dec. 11, 2016 02:45 AM EST Reads: 926
Dec. 11, 2016 02:45 AM EST Reads: 1,808
SYS-CON Events has announced today that Roger Strukhoff has been named conference chair of Cloud Expo and @ThingsExpo 2017 New York. The 20th Cloud Expo and 7th @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "The Internet of Things brings trillions of dollars of opportunity to developers and enterprise IT, no matter how you measure it," stated Roger Strukhoff. "More importantly, it leverages the power of devices and the Internet to enable us all to im...
Dec. 11, 2016 02:30 AM EST Reads: 1,076